文献速递眼底病与葡萄膜炎

60至100岁老年人年龄相关性黄斑变性对视力相关生活质量的影响:一项横断面研究

Vision-related quality of life impact of age-related macular degeneration in older adults aged 60-100 years: a cross-sectional study.
PubMed 文献 · Br J Ophthalmol · 2025-06-23

该横断面研究纳入2361名60-101岁新加坡老年人,评估年龄相关性黄斑变性(AMD)患病率及其与年龄对视力相关生活质量(VRQoL)的交互影响。结果显示任何AMD、早期AMD和晚期AMD患病率分别为6.2%、4.4%和1.8%,且随年龄增长而升高。≥80岁伴晚期AMD者较60-79岁无AMD者总体、视觉功能和情感健康评分分别差30.1%、21.0%和29.7%(均p≤0.001),仅该组达到统计学和临床意义的VRQoL下降。

要点

  • 任何AMD、早期AMD和晚期AMD的总体患病率分别为6.2%、4.4%和1.8%。
  • ≥80岁伴晚期AMD者较60-79岁无AMD者总体、视觉功能和情感健康评分分别差30.1%、21.0%和29.7%(均p≤0.001)。
  • 仅≥80岁伴晚期AMD者表现出统计学和临床意义的VRQoL下降。

核心结论

  • AMD在老龄亚洲人群中常见,对视觉功能和情感健康有显著影响。
  • 研究结果支持早期发现视觉功能下降和心理健康问题,以及预防老年患者进展为晚期AMD的策略。

研究设计与样本

  • 横断面研究,纳入来自新加坡老年人人口健康与眼病概况研究的2361名60-101岁参与者(2017-2022年)。
  • 采用改良威斯康星分级系统对早期和晚期AMD进行分级。
  • 使用简要视觉损伤影响问卷的Rasch转换总体、视觉功能和情感健康评分评估VRQoL。

主要发现

  • 任何AMD、早期AMD和晚期AMD的总体患病率分别为6.2%、4.4%和1.8%。
  • 任何AMD、早期AMD和晚期AMD的年龄别患病率在60-79、70-79和80+岁三组中分别为4.1%、7.2%、12.9%;3.0%、4.7%、9.3%;1.1%、2.5%、3.5%。
  • ≥80岁伴晚期AMD者较60-79岁无AMD者总体、视觉功能和情感健康评分分别差30.1%、21.0%和29.7%(均p≤0.001)。
  • 仅≥80岁伴晚期AMD者表现出统计学和临床意义的VRQoL下降(临床意义定义为≥0.5 SD的队列基线VRQoL评分)。

关键数值与推荐

  • VRQoL下降达到临床意义的标准为≥0.5 SD的队列基线VRQoL评分。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We evaluated the prevalence of age-related macular degeneration (AMD) and its interplay with age in influencing vision-related quality of life (VRQoL) in older Asians. METHODS: We included 2361 participants aged 60-101 years from the Population Health and Eye Disease Profile in Elderly Singaporeans cross-sectional study (2017-2022). Early and late AMD were graded using the modified Wisconsin grading system. VRQoL was assessed using Rasch-transformed overall, visual functioning and emotional well-being scores of the Brief Impact of Visual Impairment questionnaire. We calculated the prevalence of AMD and used multivariable regression models to assess the associations between AMD and age on VRQoL. VRQoL reduction was deemed clinically meaningful if ≥0.5 SD of the cohort's baseline VRQoL scores. RESULTS: The overall prevalence of any, early and late AMD was 6.2%, 4.4% and 1.8%, respectively. The age-specific prevalence increased progressively with age; that is, any AMD (4.1%, 7.2%, 12.9%), early AMD (3.0%, 4.7%, 9.3%) and late AMD (1.1%, 2.5%, 3.5%) across the three age groups (60-79, 70-79 and 80+), respectively. Participants aged ≥80 with late AMD experienced 30.1%, 21.0% and 29.7% poorer overall, visual functioning and emotional well-being, respectively (all p≤0.001), compared with those aged 60-79 without AMD. Importantly, only those aged ≥80 with late AMD demonstrated both statistically and clinically meaningful VRQoL reductions. CONCLUSIONS: AMD is prevalent in ageing Asians and has a substantial impact on visual functioning and emotional well-being. Our findings support early detection of declining visual functioning and mental health and strategies to prevent progression to late-stage AMD in older patients.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Vu TA, Fenwick EK, Man REK, et al. Vision-related quality of life impact of age-related macular degeneration in older adults aged 60-100 years: a cross-sectional study. Br J Ophthalmol. 2025. PMID: 40240124. doi:10.1136/bjo-2024-325713

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。